Multi-million-pound UK-wide research into cancer immunotherapy
The Francis Crick Institute and The Royal Marsden NHS Foundation [...]
Genes reveal risk of recurrence of kidney cancer
Looking at a person's DNA using a technique called DNA [...]
Individualising first line treatment for advanced kidney cancer
In recent years, a number of new, effective treatments have [...]
Selecting therapy for poor-risk advanced kidney cancer
In this video interview, Dr Earle Burgess from the Levine [...]
Rational approaches to treatment duration with immunotherapy for kidney cancer
A recent review of the use of immune checkpoint inhibitors [...]
Individualised treatment plans improve outcomes for kidney cancer
Over the past couple of years there have been several [...]
Personalised immunotherapy for advanced kidney cancer
In this video interview, Dr David Braun from the Dana-Farber [...]
Data-driven approach to personalised care
One of the greatest strengths of the NHS is its [...]
NHS to fast-track cancer drugs that target genetic mutations
The NHS is preparing to fast-track the introduction of ‘game [...]
Personalised vaccine to be tested in patients with kidney cancer
Scientists at the Dana-Farber Cancer Institute in Boston, USA, are [...]
